Immunohistological staining for IDO1 in tumor sections indicated that the NCI-H69 small cell lung cancer and MDA-MB231 breast cancer markedly differed in their IDO1 expression levels, with higher IDO1 expression observed in the NCI-H69 than in the MDA-MB231 (figure 1D). This evidence concerns the gene IDO1 and breast cancer.